208 related articles for article (PubMed ID: 33667117)
1. Global Governance of Human Genome Editing: What Are the Rules?
Marchant GE
Annu Rev Genomics Hum Genet; 2021 Aug; 22():385-405. PubMed ID: 33667117
[TBL] [Abstract][Full Text] [Related]
2. Making sense of heritable human genome editing: Scientific and ethical considerations.
Greenfield A
Prog Mol Biol Transl Sci; 2021; 182():1-28. PubMed ID: 34175039
[TBL] [Abstract][Full Text] [Related]
3. How Should We Regulate Heritable Human Genome Editing in Australia?
Nicol D; Rudge C; Paxton R; Niemeyer S
J Law Med; 2022 Jun; 29(2):322-336. PubMed ID: 35819374
[TBL] [Abstract][Full Text] [Related]
4. What Is Prudent Governance of Human Genome Editing?
Schweikart SJ
AMA J Ethics; 2019 Dec; 21(12):E1042-1048. PubMed ID: 31876467
[TBL] [Abstract][Full Text] [Related]
5. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
6. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
Burbery R
J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
[TBL] [Abstract][Full Text] [Related]
7. A glance at genome editing with CRISPR-Cas9 technology.
Barman A; Deb B; Chakraborty S
Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
[TBL] [Abstract][Full Text] [Related]
8. Human Germ Line and Heritable Genome Editing: The Global Policy Landscape.
Baylis F; Darnovsky M; Hasson K; Krahn TM
CRISPR J; 2020 Oct; 3(5):365-377. PubMed ID: 33095042
[TBL] [Abstract][Full Text] [Related]
9. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
10. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
Bellver Capella V
Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
[TBL] [Abstract][Full Text] [Related]
11. Heritable Genome Editing and the Downsides of a Global Moratorium.
Macintosh KL
CRISPR J; 2019 Oct; 2(5):272-279. PubMed ID: 31599680
[TBL] [Abstract][Full Text] [Related]
12. Responsible governance of human germline genome editing in China†.
Peng Y; Lv J; Ding L; Gong X; Zhou Q
Biol Reprod; 2022 Jul; 107(1):261-268. PubMed ID: 35640230
[TBL] [Abstract][Full Text] [Related]
13. Legality of Embryonic Gene Editing in Australia.
Taylor-Sands M; Gyngell C
J Law Med; 2018 Dec; 26(2):356-373. PubMed ID: 30574724
[TBL] [Abstract][Full Text] [Related]
14. Human genome editing: how to prevent rogue actors.
Townsend BA
BMC Med Ethics; 2020 Oct; 21(1):95. PubMed ID: 33023591
[TBL] [Abstract][Full Text] [Related]
15. Ethics of Human Genome Editing.
Coller BS
Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366
[TBL] [Abstract][Full Text] [Related]
16. [Control (editing) of the genome within reach, or already in our hands?].
Brdička R; Omelka R
Cas Lek Cesk; 2018; 157(2):79-83. PubMed ID: 29790357
[TBL] [Abstract][Full Text] [Related]
17. Islamic Perspectives on CRISPR/Cas9-Mediated Human Germline Gene Editing: A Preliminary Discussion.
Isa NM; Zulkifli NA; Man S
Sci Eng Ethics; 2020 Feb; 26(1):309-323. PubMed ID: 30830592
[TBL] [Abstract][Full Text] [Related]
18. [Genome Editing with CRISPR/Cas9: First Steps Towards a new Era in Medicine?].
Schermer B; Benzing T
Dtsch Med Wochenschr; 2019 Feb; 144(4):276-281. PubMed ID: 30759475
[TBL] [Abstract][Full Text] [Related]
19. Why Include the Public in Genome Editing Governance Deliberation?
Blasimme A
AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471
[TBL] [Abstract][Full Text] [Related]
20. Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
Li X; Bai Y; Cheng X; Kalds PGT; Sun B; Wu Y; Lv H; Xu K; Zhang Z
FEBS J; 2018 Sep; 285(18):3362-3375. PubMed ID: 30085411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
